Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.

Yuka AsanoShinichiro KashiwagiWataru GotoKoji TakadaKatsuyuki TakahashiTakaharu HatanoSatoru NodaTsutomu TakashimaNaoyoshi OnodaShuhei TomitaHisashi MotomuraMasahiko OhsawaKosei HirakawaMasaichi Ohira

Published in: BMC cancer (2017)

The results of the present study suggest that RCB-TILs is a significant predictor for breast cancer recurrence after NAC and may be a more sensitive indicator than TILs alone.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
papillary thyroid
transcription factor
squamous cell
squamous cell carcinoma
radiation therapy
peripheral blood
rectal cancer
lymph node metastasis